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Clomipramine (CLI) is a tricyclic serotonin reuptake blocker, widely used to treat 
depression, obsessive compulsive disorder (OCD), and other psychiatric conditions in 
human patients. Chronic CLI administration in the neonate rodent alters serotonergic 
circuits and serotonine levels in the brain, and has been reported to cause a complex 
pattern of behavioral changes in the adult life, including abnormalities of rapid eye 
movement sleep, decreased aggression and sexual behavior, anhaedonia and helpless-
ness. Such symptoms suggest a parallel with humans endogenous depression and 
have been proposed as a novel animal model of OCD. The present study was aimed 
at identifying morphological and cellular changes after chronic neonatal treatment 
with clomipramine (daily i.p. injections, 20 mg/kg, from P5 to P21) in the brain of 5 
month-old male Sprague-Dawley rats, compared to saline-treated littermates, using 
three distinct experimental approaches.
1) In vivo volumetric analyses based on structural MRI scans performed at 4.7T 
on 6 CLI-treated and 6 control rats revealed a signifi cant reduction in total brain and 
hippocampal volume, as well as enlarged ventricles in CLI-treated rats, compared to 
saline-treated cohorts.
2) In order to investigate treatment-related developmental disorders, we studied 
the dendritic arborization of newly generated cells in the hippocampus of 7 CLI and 
7 control rats. Two-dimensional dendritic tracing diagrams were reconstructed with 
Neurolucida, and quantitative analyses of total dendritic length and arborization 
indices in the two groups are still ongoing.
3) Brain-derived neurotrophic factor (BDNF) levels were assessed in the hip-
pocampus and neocortex of 5 CLI and 5 control rats by ELISA assay. Interestingly, 
we found signifi cant region-specifi c, between-group diff erences. In particular, BDNF 
levels, important for neurogenesis, diff erentiation and neuronal survival, and highly 
expressed in brain areas involved in cognitive and emotional behavior, were signifi -
cantly decreased in the hippocampus of CLI rats compared to controls, whereas no 
diff erences were found in the cortex.
Taken together, the data suggest that interfering with serotonergic regulation dur-
ing early postnatal development can produce permanent brain changes. These resem-
ble brain abnormalities repeatedly observed not only in human depression but also in 
schizophrenia. Further morphological analyses as well as experiments aimed at char-
acterizing the behavioral correlates of early CLI administration are in progress.
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